Covid vaccine sales push Moderna past expectations in Q2, shares surge ...Middle East

Business Standard - Economy
Better-than-expected COVID-19 vaccine sales pushed Moderna past Wall Street's second-quarter forecasts on Wednesday. The company said that its Spikevax vaccine brought in USD 4.53 billion during the quarter. Analysts were looking for around USD 3.6 billion, according to FactSet. Moderna shares surged at the start of trading on Wednesday. The company's vaccine sales represent a drop from the nearly USD 6 billion in sales the vaccine brought in during the year's first quarter, when a virus surge through the United States pushed more people to seek protection. But those sales could pick up again later this year. Moderna has developed an updated version of its vaccine for a fall booster campaign

Hence then, the article about covid vaccine sales push moderna past expectations in q2 shares surge was published today ( ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Covid vaccine sales push Moderna past expectations in Q2, shares surge )

Apple Storegoogle play

Last updated :

Also on site :



Latest News